Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: A multicenter, retrospective analysis in Japan

We conducted a multicenter, retrospective study to determine the anatomical distribution and prognostic factors of gastrointestinal (GI) follicular lymphoma (FL). This study included 125 patients with stage I and II1 GI–FL. Of the 125 patients, the small intestine was examined in 70 patients, with double‐balloon endoscopy and/or capsule endoscopy. The most frequently involved GI–FL site was the duodenal second portion (DSP) (81%), followed by the jejunum (40%); 85% of patients with involvement of the DSP also had jejunal or ileal lesions. The absence of abdominal symptoms and macroscopic appearance of multiple nodules were significantly present in the DSP‐positive group. During a median follow up of 40 months, six patients showed disease progression. Patients with involvement of the DSP had better progression‐free survival (PFS) than those without such involvement (P = 0.001). A multivariate analysis revealed that male sex, the presence of abdominal symptoms, and negative involvement of the DSP were independently associated with poor PFS. In conclusion, most patients with GI–FL have duodenal lesions associated with multiple jejunal or ileal lesions. Gastrointestinal follicular lymphomas involving the DSP might be a distinct entity showing a favorable clinical course. (Cancer Sci 2011; 102: 1532–1536)

[1]  Y. Matsuno,et al.  The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  K. Takata,et al.  Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations , 2009, Modern Pathology.

[3]  R. Takayanagi,et al.  Impact of double-balloon endoscopy on the diagnosis of jejunoileal involvement in primary intestinal follicular lymphomas: a case series. , 2009, Endoscopy.

[4]  T. Naoe,et al.  Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Chayama,et al.  Primary follicular lymphoma of the gastrointestinal tract: a retrospective case series , 2007, Endoscopy.

[6]  K. Ichimura,et al.  Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas , 2007, Journal of Clinical Pathology.

[7]  M. Calaminici,et al.  Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H. Tagawa,et al.  CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. , 2007, Blood.

[9]  B. Sander,et al.  CD8+ T-Cell Content in Diagnostic Lymph Nodes Measured by Flow Cytometry Is a Predictor of Survival in Follicular Lymphoma , 2007, Clinical Cancer Research.

[10]  Pinpin Lin,et al.  Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung Adenocarcinomas , 2007, Clinical Cancer Research.

[11]  P. Solal-Céligny,et al.  Follicular lymphoma international prognostic index , 2006, Blood.

[12]  M. Czuczman,et al.  Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. Molina,et al.  Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  J. Teruya-Feldstein,et al.  Primary Follicular Lymphoma of the Gastrointestinal Tract: A Clinical and Pathologic Study of 26 Cases , 2002, The American journal of surgical pathology.

[15]  H. Müller-Hermelink,et al.  Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. , 2000, Gastroenterology.

[16]  T. Yoshino,et al.  Increased incidence of follicular lymphoma in the duodenum. , 2000, The American journal of surgical pathology.

[17]  D. Weisenburger,et al.  Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  T. Yoshino,et al.  Gastric low‐grade mucosa‐associated lymphoid tissue lymphomas: Their histogenesis and high‐grade transformation , 1998, Pathology international.

[19]  B. Coiffier,et al.  Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Takeshi Takahashi,et al.  Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma , 2009, Journal of Cancer Research and Clinical Oncology.

[21]  H. Suekane,et al.  Endoscopic features of intestinal follicular lymphoma: the value of double-balloon enteroscopy. , 2007, Endoscopy.

[22]  M. Seto,et al.  Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK , 2001, Leukemia.